The phenotypic evolution of pseudomonas aeruginosa populations changes in the presence of subinhibitory concentrations of ciprofloxacin

Microbiology (United Kingdom)

Volumn 162, Issue 5, 2016, Pages 865-875

  Wassermann, Tina ^a   Jørgensen, Karin Meinike ^b   Ivanyshyn, Karolina ^b,d   Bjarnsholt, Thomas ^a,b   Hossein Khademi, S M ^c   Jelsbak, Lars ^c   Høiby, Niels ^a,b   Ciofu, Oana ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d Biotechnology Engineering School   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROTEINASE; TOBRAMYCIN; ANTIINFECTIVE AGENT; PROTEIN MUTS; TYPE III SECRETION SYSTEM; VIRULENCE FACTOR;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; DENITRIFICATION; DNA MICROARRAY; ENZYME ACTIVITY; NONHUMAN; NUTRITIONAL STATUS; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONADACEAE; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; TYPE III SECRETION SYSTEM; UPREGULATION; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PATHOGENICITY;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DENITRIFICATION; MICROBIAL SENSITIVITY TESTS; MUTS DNA MISMATCH-BINDING PROTEIN; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; TYPE III SECRETION SYSTEMS; VIRULENCE FACTORS;

EID: 84964933310     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.000273     Document Type: Article

References (57)

1. Andersson, D. I. & Hughes, D. (2014). Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 12, 465-478
2. Becher, A. & Schweizer, H. P. (2000). Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions. Biotechniques 29, 948-950, 952
3. Bjarnsholt, T., Jensen, P. O., Jakobsen, T. H., Phipps, R., Nielsen, A. K., Rybtke, M. T., Tolker-Nielsen, T., Givskov, M., Høiby, N., Ciofu, O. & Scandinavian Cystic Fibrosis Study Consortium (2010). Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS One 5, e10115
4. Blázquez, J., Couce, A., Rodríguez-Beltrán, J. & Rodríguez-Rojas, A. (2012). Antimicrobials as promoters of genetic variation. Curr Opin Microbiol 15, 561-569
5. Brazas, M. D. & Hancock, R. E. (2005). Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49, 3222-3227
6. Brazas, M. D., Breidenstein, E. B., Overhage, J. & Hancock, R. E. (2007). Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin. Antimicrob Agents Chemother 51, 4276-4283
7. Brochmann, R. P., Toft, A., Ciofu, O., Briales, A., Kolpen, M., Hempel, C., Bjarnsholt, T., Høiby, N. & Jensen, P. O. (2014). Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation. Int J Antimicrob Agents 43, 140-147
8. Ciofu, O., Mandsberg, L. F., Bjarnsholt, T., Wassermann, T. & Høiby, N. (2010). Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156, 1108-1119
9. Cirz, R. T., O’Neill, B. M., Hammond, J.A., Head, S.R. & Romesberg, F. E. (2006).Defining the Pseudomonas aeruginosaSOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol 188, 7101-7110
10. Dwyer, D. J., Kohanski, M. A. & Collins, J. J. (2009). Role of reactive oxygen species in antibiotic action and resistance. Curr Opin Microbiol 12, 482-489
11. Edgar, R., Domrachev, M. & Lash, A. E. (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30, 207-210
12. Fàbrega, A., Madurga, S., Giralt, E. & Vila, J. (2009). Mechanism of action of and resistance to quinolones. Microb Biotechnol 2, 40-61
13. Gambello, M. J. & Iglewski, B. H. (1991). Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 173, 3000-3009
14. Gocke, E. (1991). Mechanism of quinolone mutagenicity in bacteria. Mutat Res 248, 135-143
15. Gustafsson, I., Sjölund, M., Torell, E., Johannesson, M., Engstrand, L., Cars, O. & Andersson, D. I. (2003). Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother 52, 645-650
16. Ha, D. G., Kuchma, S. L. & O’Toole, G. A. (2014). Plate-based assay for swimming motility in Pseudomonas aeruginosa. Methods Mol Biol 1149, 59-65
17. Hall, B. M., Ma, C. X., Liang, P. & Singh, K. K. (2009). Fluctuation analysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbruck fluctuation analysis. Bioinformatics 25, 1564-1565
18. Hansen, S. K., Rau, M. H., Johansen, H. K., Ciofu, O., Jelsbak, L., Yang, L., Folkesson, A., Jarmer, H. O., Aanæs, K. & other authors (2012). Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 6, 31-45
19. Hassett, D. J., Ma, J. F., Elkins, J. G., McDermott, T. R., Ochsner, U. A., West, S. E., Huang, C. T., Fredericks, J., Burnett, S. & other authors (1999). Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol Microbiol 34, 1082-1093
20. Hauser, A. R. (2009). The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7, 654-665
21. Herrero, M., de Lorenzo, V. & Timmis, K. N. (1990). Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gramnegative bacteria. J Bacteriol 172, 6557-6567
22. Hoang, T. T., Kutchma, A. J., Becher, A. & Schweizer, H. P. (2000). Integration-proficient plasmids for Pseudomonas aeruginosa: sitespecific integration and use for engineering of reporter and expression strains. Plasmid 43, 59-72
23. Høiby, N., Jarløv, J.O., Kemp, M., Tvede, M., Bangsborg, J. M., Kjerulf, A., Pers, C. & Hansen, H. (1997). Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 349, 167-169
24. Holloway, B. W. (1955). Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13, 572-581
25. Hong, C. S., Shitashiro, M., Kuroda, A., Ikeda, T., Takiguchi, N., Ohtake, H. & Kato, J. (2004). Chemotaxis proteins and transducers for aerotaxis in Pseudomonas aeruginosa. FEMS Microbiol Lett 231, 247-252
26. Hurley, M. & Smyth, A. (2012). Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis. Ther Adv Respir Dis 6, 363-373
27. Jansen, G., Crummenerl, L. L., Gilbert, F., Mohr, T., Pfefferkorn, R., Thänert, R., Rosenstiel, P. & Schulenburg, H. (2015). Evolutionary transition from pathogenicity to commensalism: global regulator mutations mediate fitness gains through virulence attenuation. Mol Biol Evol 32, 2883-2896
28. Jørgensen, K. M., Wassermann, T., Jensen, P. O., Hengzuang, W., Molin, S., Høiby, N. & Ciofu, O. (2013). Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa. Antimicrob Agents Chemother 57, 4215-4221
29. Jørgensen, K. M., Wassermann, T., Johansen, H. K., Christiansen, L. E., Molin, S., Høiby, N. & Ciofu, O. (2015). Diversity of metabolic profiles of cystic fibrosis Pseudomonas aeruginosa during the early stages of lung infection. Microbiology 161, 1447-1462
30. Jyet, J. & Ramphal, R. (2008). Flagella and pili of Pseudomonas aeruginosa. In Pseudomonas: Model Organism, Pathogen and Cell Factory, pp. 85-108. Edited by B. H. A. Rehm. Oxford: Wiley- Blackwell.
31. Kessler, E. & Safrin, M. (2014). Elastinolytic and proteolytic enzymes. Methods Mol Biol 1149, 135-169
32. Kohanski, M. A., DePristo, M. A. & Collins, J. J. (2010). Sublethal antibiotic treatment leads to multidrug resistance via radicalinduced mutagenesis. Mol Cell 37, 311-320
33. Köhler, T., Perron, G. G., Buckling, A. & van Delden, C. (2010). Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog 6, e1000883
34. Linares, J. F., Gustafsson, I., Baquero, F. & Martinez, J. L. (2006). Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A 103, 19484-19489
35. Line, L., Alhede, M., Kolpen, M., Kühl, M., Ciofu, O., Bjarnsholt, T., Moser, C., Toyofuku, M., Nomura, N. & other authors (2014). Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum. Front Microbiol 5, 554
36. Mandsberg, L. F., Ciofu, O., Kirkby, N., Christiansen, L. E., Poulsen, H. E. & Høiby, N. (2009). Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. Antimicrob Agents Chemother 53, 2483-2491
37. Markussen, T., Marvig, R. L., Gómez-Lozano, M., Aanæs, K., Burleigh, A. E., Høiby, N., Johansen, H. K., Molin, S. & Jelsbak, L. (2014). Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. MBio 5, e01592-e01514
38. Masuda, N., Gotoh, N., Ishii, C., Sakagawa, E., Ohya, S. & Nishino, T. (1999). Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to betalactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother 43, 400-402
39. Morita, Y., Kimura, N., Mima, T., Mizushima, T. & Tsuchiya, T. (2001). Roles of MexXY- and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1. J Gen Appl Microbiol 47, 27-32
40. Mulet, X., Moyá, B., Juan, C., Macià, M. D., Pérez, J. L., Blázquez, J. & Oliver, A. (2011). Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth. Antimicrob Agents Chemother 55, 4560-4568
41. Nair, C. G., Chao, C., Ryall, B. & Williams, H. D. (2013). Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogen Pseudomonas aeruginosa. Lett Appl Microbiol 56, 149-154
42. Newman, J. R. & Fuqua, C. (1999). Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator. Gene 227, 197-203
43. Olivares, J., Álvarez-Ortega, C. & Martinez, J. L. (2014). Metabolic compensation of fitness costs associated with overexpression of the multidrug efflux pump MexEF-OprN in Pseudomonas aeruginosa. Antimicrob Agents Chemother 58, 3904-3913
44. Palmer, K. L., Mashburn, L. M., Singh, P. K. & Whiteley, M. (2005). Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187, 5267-5277
45. Poole, K. (2011). Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2, 65
46. Rainey, P. B., Buckling, A., Kassen, R. & Travisano, M. (2000). The emergence and maintenance of diversity: insights from experimental bacterial populations. Trends Ecol Evol 15, 243-247
47. Rakhimova, E., Munder, A., Wiehlmann, L., Bredenbruch, F. & Tümmler, B. (2008). Fitness of isogenic colony morphology variants of Pseudomonas aeruginosa in murine airway infection. PLoS One 3, e1685
48. Schuster, M. & Greenberg, E. P. (2006). A network of networks: quorum-sensing gene regulation in Pseudomonas aeruginosa. Int J Med Microbiol 296, 73-81
49. Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Høiby, N. & Givskov, M. (2008). Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 52, 3648-3663
50. Stephenson, K. & Hoch, J. A. (2002). Two-component and phosphorelay signal-transduction systems as therapeutic targets. Curr Opin Pharmacol 2, 507-512
51. Taguchi, K., Fukutomi, H., Kuroda, A., Kato, J. & Ohtake, H. (1997). Genetic identification of chemotactic transducers for amino acids in Pseudomonas aeruginosa. Microbiology 143, 3223-3229
52. Tanimoto, K., Tomita, H., Fujimoto, S., Okuzumi, K. & Ike, Y. (2008). Fluoroquinolone enhances the mutation frequency for meropenemselected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation. Antimicrob Agents Chemother 52, 3795-3800
53. Toder, D. S., Gambello, M. J. & Iglewski, B. H. (1991). Pseudomonas aeruginosa LasA: a second elastase under the transcriptional control of lasR. Mol Microbiol 5, 2003-2010
54. Torres-Barceló, C., Kojadinovic, M., Moxon, R. & MacLean, R. C. (2015). The SOS response increases bacterial fitness, but not evolvability, under a sublethal dose of antibiotic. Proc Biol Sci 282, 20150885
55. Wong, A. & Kassen, R. (2011). Parallel evolution and local differentiation in quinolone resistance in Pseudomonas aeruginosa. Microbiology 157, 937-944
56. Wong, A., Rodrigue, N. & Kassen, R. (2012). Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Genet 8, e1002928
57. Zumft, W. G. (1997). Cell biology and molecular basis of denitrification. Microbiol Mol Biol Rev 61, 533-616.